# Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.

> PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41083011-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41083011-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41083011-semaglutide-v1.json
- Content SHA-256: `f26075e2fe8e3fdb3007d54a7ef9bdfc91be2969f22f563f899352f3b51633c3`

## Claims and source pins

### Headline

Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density. ([`pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4`](#source-pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4))

### Summary

PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4`](#source-pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4))

### Paragraph 1

PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4`](#source-pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4`](#source-pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4))

## Sources

<a id="source-pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4"></a>
- **Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density. · retained source version 1:2026-06-29:current:34a9ec8bd4a40f52ec7370dba17e894b245c25404247f07518af2adf9ce77b3a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41083011/) (`pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41083011-semaglutide-v1.json SHA-256: f26075e2fe8e3fdb3007d54a7ef9bdfc91be2969f22f563f899352f3b51633c3.